- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02262390
Syphilis Treatment of Partners Trial (STOP)
Comparison of Different Partner Notification Strategies After Antenatal Syphilis Screening
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Title: Comparison of Different Partner Notification Strategies after Antenatal Syphilis Screening Short Title: Syphilis Treatment of Partners (STOP) Trial Objectives: Primary For pregnant women who test rapid syphilis test positive; to compare the proportion of male partners who report to the clinic for syphilis testing (and treatment) when the women are given only partner notification slips (standard of care) compared to a notification slip plus a weekly automated SMS reminder OR a notification slip plus a weekly nurse phone call reminder.
Secondary
- To compare the proportion of male partners who test positive for syphilis when they report to the clinic after receiving notification in the three groups via their pregnant partners.
- To compare the proportion of male partners who undergo treatment among the three groups.
- To explore factors associated with reporting/not reporting after notification.
- To compare birth outcomes (congenital syphilis, stillbirths, neonatal deaths, preterm or low birth weight) between the three arms (self-reported by women).
- To assess time from syphilis point of care (POC) test to treatment in mothers who test syphilis positive using a rapid treponemal antibody kit.
- To compare the proportion of women who have a 4-fold decrease in RPR titer by intervention arm in each arm at post natal visit.
Study Population and sample size: • Pregnant women from 14years and above reporting to antenatal and subsequently postnatal clinics at the Infectious Disease Institute, Mulago Hospital (antenatal and STI clinics), and Kasangati Health Center IV in Kampala, Uganda who screen positive by rapid treponemal antibody test.
- Male sexual partners to these enrolled syphilis positive pregnant mothers.
- 876participants will be enrolled. Study Design: Individual patient randomized open-label clinical trial of syphilis partner notification interventions.
Study Duration: Approximately 24 months
Endpoints:
Primary:
1) Proportion of male partners who present at clinic and receive syphilis testing
Secondary:
- Male partners tested (standard vs. intervention in 3 arm randomization)
- Proportion of male partners who test positive for syphilis when they report to the clinic after notification.
- Proportion of syphilis positive male (tested by syphilis POCT) partners who undergo treatment among the three groups.
- Factors associated with partners reporting/not reporting after notification.
- Syphilis infected pregnant women re-tested in 3rd trimester with a 4-fold dilutional titer decrease in RPR (by standard vs. intervention arm)
- Mother reported birth outcomes (by standard vs. intervention arm) Subject Participants: Pregnant women testing positive for syphilis at the antenatal clinics and their partners.
Description of Study Design: This is a prospective clinical trial in which pregnant syphilis positive women (tested by rapid treponemal antibody kit) will be randomized to one of three arms to notify participants to bring their sexual partners at risk for syphilis for syphilis screening and treatment. Women will be randomized in a 1:1:1 ratio to one of the following three strategies: A) To receive a notification slip per the Ministry of Health standard B) to receive a notification slip plus an SMS reminder or C) to receive a notification slip plus standardized nurse/clinician initiated phone call.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Rosalind Parkes-Ratanshi, PhD
- Phone Number: 237 +256312307000
- Email: rratanshi@idi.co.ug
Study Contact Backup
- Name: Joshua K Mbazira, CO
- Phone Number: 310 +256312307000
- Email: jmbazira@idi.co.ug
Study Locations
-
-
-
Kampala, Uganda, 256
- Infectious Diseases Institute
-
Contact:
- Rosalind Parkes-Ratanshi, PhD
- Phone Number: 237 +256312307000
- Email: rratanshi@idi.co.ug
-
Sub-Investigator:
- Edith Nakku-Joloba, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Individuals must meet all of the following inclusion criteria in order to be eligible to participate:
- Pregnant women
- Treponemal antibody rapid positive test
- Age> 14 years
- Written informed consent
- Known sexual partner
- Access to cell phone and willing and able to use and receive SMS or phone calls In the Uganda guidelines (section 9.3 Mature and Emancipated Minors), "mature minors are individuals 14-17 years of age who have drug or alcohol dependency or a sexually transmitted infection; Mature minors may independently provide informed consent to participate in research if in the view of the IRC the research is not objectionable to parents or guardian (established by the IRC with evidence from the community); and b) The research protocol include clear justification for targeting mature and emancipated." This protocol will recruit pregnant women with a sexually transmitted infection in an intervention with minimal risk and with the potential to prevent future reinfection.
Exclusion Criteria:
Any subjects meeting any of the following exclusion criteria at baseline will be excluded from study participation:
- Illiterate and unable to read a text message
- Inability to use a mobile phone
- Patients with confirmed neuro syphilis treated with IV Benzyl penicillin
Study Plan
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Standard of Care
Partner notification slip is given to the pregnant female participant on the day she receives her syphilis test results to give to their sexual partner encouraging them to come to the STI clinic and be screened for syphilis.
The partner notification slip will have a code number, but no identifiable features (no names).
|
For all 3 arms, the following will be done:
|
ACTIVE_COMPARATOR: SMS reminders and notification slip for partner screening
Participants will receive weekly SMS reminders to encourage their partners to attend the STI clinic for syphilis testing for up to 8 weeks after initial positive syphilis test for the participant.
The participant ID number will be written on both the notification paper which partners should bring in with them and on the SMS reminders.
|
For all 3 arms, the following will be done:
|
ACTIVE_COMPARATOR: Phone call reminders and notification slip for partner scree
Participants will receive weekly phone call reminders to encourage their partners to attend the STI clinic for syphilis testing for up to 8 weeks after initial positive syphilis test for the participant.
The participant ID number will be written on both the notification paper which partners should bring in with them and be given to the participant when the nurse calls.
|
For all 3 arms, the following will be done:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of male partners who present at clinic and receive syphilis testing
Time Frame: 2 years
|
Proportion of male partners who present at clinic and receive syphilis testing
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Male partners tested (standard vs. intervention in 3 arm randomization)
Time Frame: 2 years
|
Male partners tested (standard vs. intervention in 3 arm randomization)
|
2 years
|
Proportion of male partners who test positive for syphilis when they report to the clinic after notification.
Time Frame: 2 years
|
Proportion of male partners who test positive for syphilis when they report to the clinic after notification.
|
2 years
|
Proportion of syphilis positive male (tested by syphilis POCT) partners who undergo treatment among the three groups.
Time Frame: 2 years
|
Proportion of syphilis positive male (tested by syphilis POCT) partners who undergo treatment among the three groups.
|
2 years
|
Factors associated with partners reporting/not reporting after notification.
Time Frame: 2 years
|
Factors associated with partners reporting/not reporting after notification.
|
2 years
|
Syphilis infected pregnant women re-tested in 3rd trimester with a 4-fold dilutional titer decrease in RPR (by standard vs. intervention arm)
Time Frame: 2 years
|
Syphilis infected pregnant women re-tested in 3rd trimester with a 4-fold dilutional titer decrease in RPR (by standard vs. intervention arm)
|
2 years
|
Mother reported birth outcomes (by standard vs. intervention arm)
Time Frame: 2 years
|
Mother reported birth outcomes (by standard vs. intervention arm)
|
2 years
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Yuka C Manabe, MD, Johns Hopkins University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ST/0109/14
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Syphilis Infection
-
Hospital de Niños R. Gutierrez de Buenos AiresCompleted
-
MedMira Laboratories Inc.Public Health Agency of Canada (PHAC)RecruitingSyphilis | Syphilis Infection | Early Syphilis, SymptomaticCanada
-
NOWDiagnostics, Inc.CompletedSyphilis Infection | Treponema Pallidum InfectionUnited States
-
University of WashingtonNational Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaboratorsActive, not recruitingHIV Infections | HIV/AIDS | Neisseria Gonorrheae Infection | Chlamydia Trachomatis Infection | Syphilis InfectionKenya
-
National Taiwan University HospitalChina Medical University Hospital; Kaohsiung Medical University Chung-Ho Memorial... and other collaboratorsNot yet recruitingEarly Syphilis, Latent, Serological Relapse After Treatment
-
Institut de Recherche en Sciences de la Sante,...African Population and Health Research Center; World Health OrganizationCompletedDiagnoses Disease | Syphilis Infection
-
Ottawa Hospital Research InstituteCIHR Canadian HIV Trials NetworkTerminatedSyphilis | Primary Syphilis | Secondary Syphilis | Early-Latent SyphilisCanada
-
Fundación FLS de Lucha Contra el Sida, las Enfermedades...RecruitingPrimary Syphilis | Secondary Syphilis | Early Latent SyphilisSpain, United Kingdom
-
Memorial University of NewfoundlandRecruitingHIV Infections | HCV Infection | Syphilis InfectionCanada
-
bioLytical LaboratoriesRecruitingSyphilis | Syphilis InfectionSouth Africa
Clinical Trials on Partner Notification Reminders
-
University of WashingtonUniversity of Nairobi; Kenya Ministry of HealthCompleted
-
University of North Carolina, Chapel HillCompleted
-
Lighthouse TrustUnited States Agency for International Development (USAID); Centers for Disease... and other collaboratorsUnknown
-
Fundacio d'Investigacio en Atencio Primaria Jordi...Institut Català d'OncologiaUnknown
-
University of Alabama at BirminghamNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
University of North Carolina, Chapel HillNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
University of BristolCompleted
-
Kaiser PermanenteUniversity of Colorado, Denver; National Institute of Diabetes and Digestive... and other collaboratorsCompleted
-
University of North Carolina, Chapel HillCompletedHIV Infections | Infections | RNA Virus Infections | Blood-Borne Infections | Sexually Transmitted Diseases, Viral | Sexually Transmitted Diseases | Sexually Transmitted Diseases, Bacterial | Syphilis | Communicable Disease | Virus Disease | Neisseria Gonorrheae Infection | Chlamydia Trachomatis InfectionMalawi
-
University of PennsylvaniaHarvard University; National Bureau of Economic Research, Inc.Completed